Correlation Between MedMira and Innovent Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MedMira and Innovent Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MedMira and Innovent Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MedMira and Innovent Biologics, you can compare the effects of market volatilities on MedMira and Innovent Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MedMira with a short position of Innovent Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MedMira and Innovent Biologics.

Diversification Opportunities for MedMira and Innovent Biologics

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between MedMira and Innovent is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding MedMira and Innovent Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovent Biologics and MedMira is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MedMira are associated (or correlated) with Innovent Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovent Biologics has no effect on the direction of MedMira i.e., MedMira and Innovent Biologics go up and down completely randomly.

Pair Corralation between MedMira and Innovent Biologics

Assuming the 90 days horizon MedMira is expected to under-perform the Innovent Biologics. But the pink sheet apears to be less risky and, when comparing its historical volatility, MedMira is 120.79 times less risky than Innovent Biologics. The pink sheet trades about -0.21 of its potential returns per unit of risk. The Innovent Biologics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  457.00  in Innovent Biologics on September 1, 2024 and sell it today you would earn a total of  28.00  from holding Innovent Biologics or generate 6.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MedMira  vs.  Innovent Biologics

 Performance 
       Timeline  
MedMira 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MedMira are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, MedMira reported solid returns over the last few months and may actually be approaching a breakup point.
Innovent Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innovent Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Innovent Biologics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

MedMira and Innovent Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MedMira and Innovent Biologics

The main advantage of trading using opposite MedMira and Innovent Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MedMira position performs unexpectedly, Innovent Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovent Biologics will offset losses from the drop in Innovent Biologics' long position.
The idea behind MedMira and Innovent Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope